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The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that
heteromerization of adenosine A1 receptors (A1Rs) and A2A receptors (A2ARs) allows adenosine to exert a fine-tuning modulation of
glutamatergic neurotransmission. By means of coimmunoprecipitation, bioluminescence and time-resolved fluorescence resonance
energy transfer techniques, we showed the existence of A1R–A2AR heteromers in the cell surface of cotransfected cells. Immunogold
detection and coimmunoprecipitation experiments indicated that A1R andA2AR are colocalized in the same striatal glutamatergic nerve
terminals. Radioligand-binding experiments in cotransfected cells and rat striatum showed that amain biochemical characteristic of the
A1R–A2AR heteromer is the ability of A2AR activation to reduce the affinity of the A1R for agonists. This provides a switchmechanism by
which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamate release. Furthermore, it is also shown that
A1R–A2ARheteromers constitute a unique target for caffeine and that chronic caffeine treatment leads tomodifications in the function of
the A1R–A2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.
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Introduction
Of the four known adenosine receptors (A1, A2A, A2B, and A3), A1
receptor (A1R) and A2A receptor (A2AR) are primarily responsi-
ble for the central effects of adenosine (Dunwiddie and Masino,
2001). The same receptors are also the main target of nontoxic
psychostimulant doses of caffeine, themost consumed psychoac-
tive drug in the world (Fredholm et al., 1999). In addition to their
postsynaptic location in different brain regions, A1R and A2AR
can be found presynaptically. A1R and A2AR are coupled to Gi/o-
and Gs/olf-proteins, respectively (Dunwiddie and Masino, 2001).
Stimulation of presynaptic A1Rs receptors decreases the proba-
bility of neurotransmitter release, whereas activation of presyn-
aptic A2ARs enhances neurotransmitter release (Yawo and Chu-
hma, 1993;Wu and Saggau, 1997;O’Kane and Stone, 1998; Lopes
et al., 2002; Quarta et al., 2004b).
Previous studies have provided evidence for functional antag-
onistic interactions between A1Rs and A2ARs that modulate glu-
tamate release in the striatum and hippocampus (O’Kane and
Stone, 1998; Lopes et al., 2002; Quarta et al., 2004b). The coex-
istence of both facilitatory A2ARs and inhibitory A1Rs in the same
terminal is intriguing, particularly in view of their opposite func-
tional effects. In the present study, we use radioligand-binding,
coimmunoprecipitation, bioluminescence resonance energy
transfer (BRET) and time-resolved fluorescence resonance en-
ergy transfer (TR-FRET) techniques to demonstrate that A1R and
A2AR form A1R–A2AR heteromers in mammalian cells and in
striatal glutamatergic nerve terminals. The main biochemical
characteristic of the A1R–A2AR heteromer is the ability of A2AR
activation to reduce the affinity of the A1R for agonists, providing
a switch mechanism by which low and high concentrations of
adenosine inhibit and stimulate, respectively, glutamatergic neu-
rotransmission. The present study is the first indication that hetero-
merizationof different receptors for the samemodulator constitutes
auniqueway topresynaptically regulateneurotransmission andalso
is the first indication that A1R–A2AR heteromersmay be involved in
the acute and chronic effects of caffeine.
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Materials andMethods
Animals, cell culture, and transfection. Male Sprague Dawley or Wistar
rats (Charles River Laboratories, Wilmington, MA) were used, where
indicated. Caffeine was administered chronically by giving free access to
bottles containing a solution of 1.0 mg/ml caffeine anhydrate base
(Sigma, St. Louis, MO) in tap water for 14 d (chronic group) as the only
fluid available for drinking. HEK-293 cells were grown in DMEM
(Sigma) as described previously (Ciruela et al., 2001; Canals et al., 2003).
All animal experiments were performed in accordance with the National
Institutes of Health and Guidelines for the Care and Use of Mammals in
Neuroscience andBehavioral Research (National ResearchCouncil, 2003).
Cells were transiently transfected with the DNA encoding for the pro-
teins specified in each case by calcium phosphate precipitation. The hu-
man hemagglutinin (HA)-A2AR and Flag-A1R construct were obtained
as previously described (Ciruela et al., 2001; Canals et al., 2003). These
receptors were also subcloned in frame with either Renilla luciferase
(A2AR-Rluc) or with the enhanced yellow fluorescent protein
(A1R-YFP).
Immunoprecipitation andWestern blot analysis.Transiently transfected
HEK cells or striatal synaptosomes were solubilized in ice-cold lysis
buffer [PBS, pH 7.4, containing 1% (v/v) Nonidet P-40] for 30 min on
ice. The solubilized preparationwas then centrifuged at 13,000 g for 30
min, and the supernatant (1 mg/ml) was processed for immunoprecipi-
tation, as described previously (Ciruela et al., 2001; Canals et al., 2003).
Immune complexes in sample buffer (8 M urea, 2% SDS, 100 mM DTT,
375 mM Tris, pH 6.8) were dissociated by heating to 37°C for 2 h and
resolved by SDS-PAGE. Proteins were transferred to polyvinylidene di-
fluoridemembranes using a semidry transfer systemand immunoblotted
with the indicated primary antibody. The blots were then incubated with
a secondary horseradish peroxidase (HRP)-conjugated goat anti-rabbit
IgG antibody (1:60,000). The immunoreactive bands were developed
using a chemiluminescent detection kit. The primary antibodies used
were as follows: anti-Flag monoclonal antibody and anti-HA monoclo-
nal antibody (Sigma) and rabbit anti-A2AR and anti-A1R polyclonal an-
tibodies (Affinity BioReagents, Golden, CO). To test the specificity of the
anti-A1R polyclonal antibody in striatal tissue, a preincubation with the
immunizing peptide C(309)QPKPPIDEDLPEEKAED(326) (ab5893;
Abcam,Cambridge,MA)was performed. This preincubation completely
abrogated the staining observed in striatal tissue (data not shown).
Immunostaining. For immunochemistry, transiently transfected HEK
cells or rat striatal synaptosomes were fixed in 4% paraformaldehyde for
15 min and washed with PBS containing 20 mM glycine (buffer A) to
quench the aldehyde groups. Then, after permeabilization with buffer A
containing 0.2% Triton X-100 for 5 min, cells or striatal synaptosomes
were treated with PBS containing 1% bovine serum albumin (buffer B).
After 1 h at room temperature, cells or synaptosomes were labeled with
the indicated primary antibody for 1 h, washed, and stained with the
indicated secondary antibody. Samples were rinsed and observed in a
confocal microscope (Ciruela et al., 2001; Canals et al., 2003; Rodrigues
et al., 2005). The primary antibodies used were as follows: anti-HA
monoclonal antibody (2 g/ml; Sigma), rabbit anti-Flag polyclonal an-
tibody (2 g/ml; Sigma), mouse anti-A2AR (2 g/ml; Upstate Biotech-
nology, Lake Placid, NY), rabbit anti-A1 receptor (1:200; Affinity Biore-
agents), guinea pig anti-vGluT1 (1:5000; Chemicon, Temecula, CA) and
guinea pig anti-vGluT2 (1:5000; Chemicon). The secondary antibodies
used were as follows: Alexa Fluor 488-conjugated goat anti-mouse IgG
(1:200; Invitrogen, Eugene, OR), Texas Red-conjugated goat anti-rabbit
IgG (1:1000; Invitrogen), Alexa Fluor 598-conjugated goat anti-guinea
pig (1:200; Invitrogen), and Alexa Fluor 350-conjugated goat anti-rabbit
(1:200; Invitrogen). For ultrastructural analysis, preembedding tech-
niques for single and double labeling were used, as described previously
(Lujan et al., 1996). Briefly, free-floating sections were incubated in Tris-
buffered saline containing 10%of normal goat serum (TBS-NGS) during
1 h. After blocking, sections were incubated during 48 h with TBS-NGS
containingmouse anti-A2AR antibody (2g/ml; Upstate Biotechnology)
and/or rabbit-anti-A1R antibody (2 g/ml; Affinity Bioreagents). When
a single primary antibody was used, it was visualized by the silver-
intensified immunogold reaction. When two primary antibodies were
used, one of them (anti-A2AR antibody) was visualized by the immuno-
peroxidase reaction and the second one (anti-A1R antibody) by the
silver-intensified immunogold reaction. The following secondary anti-
bodies were used: goat anti-rabbit coupled to 1.4 nm gold, goat
anti-mouse coupled to 1.4 nm gold, and biotinylated goat anti-mouse
antibody. After washing in TBS, sections were processed and observed as
described previously (Lujan et al., 1996).
BRET and TR-FRET. Forty-eight hours after transfection, HEK cells
were rapidlywashed twice in PBS, detached, and resuspended in the same
buffer. The protein was determined using a Bradford assay kit (Bio-Rad,
Hercules, CA). To quantify A2AR-Rluc and A1R-YFP expression, a cell
suspension (20 g of protein) was distributed in duplicate into 96-well
transparent bottom microplates (Corning, Corning, NY). The fluores-
cence and luminescence were determined as described previously (Ca-
nals et al., 2003). For BRET measurement, 20 g of cell suspension was
distributed in duplicate in 96-well opaque microplates (Corning) and 5
mM coelenterazine Hwas added. After 1min, the readings were collected
by using a Fusion microplate analyzer (Packard, Meridian, CT) that
allows the integration of the signals using filters with the appropriate
bandpass. The BRET ratio is defined as [(emission at 510–590)/(emis-
sion 440–500)]  cf., where cf. corresponds to (emission at 510–590)/
(emission at 440–500) for the A2AR-Rluc construct expressed alone in
the same experiment. Time-resolved FRET was performed as described
previously (McVey et al., 2001). Briefly, transiently transfectedHEK cells
were detached, washed twice with PBS, and incubated in PBS containing
50% fetal bovine serum and 5 nM Eu3-labeled anti-Flag antibody (CIS
bio, Gif/Yvette, France) and 20 nM allophycocyanin-labeled anti-HA an-
tibody (CIS bio) during 3 h in constant rotation at room temperature.
After washing, cells were placed into a 96-well microtiter plate and ana-
lyzed using a Victor 2 (PerkinElmer,Wellesley,MA) configured for time-
resolved fluorescence.
Radioligand-binding experiments. Membrane suspensions from rat
striatum or from transfected HEK cells were obtained as described pre-
viously (Casado´ et al., 1990; Herrera et al., 2001). Displacement experi-
ments were performed by incubating (120min)membranes (0.25mg/ml
striatal protein or 0.19 mg/ml HEK cells) at 25°C in 50 mM Tris-HCl
buffer, pH 7.4, containing 10 mM MgCl2 and 2 U/ml adenosine deami-
nase (EC 3.5.4.4; Roche, Basel, Switzerland) with the indicated concen-
trations of 3H-labeled R-phenylisopropyladenosine ([ 3H]R-PIA) (30.5
Ci/mmol; Moravek Biochemicals, Brea, CA) or 3H-labeled 2-p-(2-
carboxyethyl)phenethylamino-5-N-ethylcarboxamido adenosine HCl
([ 3H]CGS21680) (45 Ci/mmol; PerkinElmer) in the absence or presence
of increasing concentrations of nonlabeled compounds (Sarrio´ et al.,
2000). Nonspecific binding was determined in the presence of 10 M
1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (Sigma) for A1Rs or 10
M ZM241385 (4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-
a][1,3,5]triazin-5-ylamino]ethyl)phenol) (Tocris, Ellisville, MO) for
binding to A2ARs. Free andmembrane-bound ligand were separated and
detected as described previously (Casado´ et al., 1990; Sarrio´ et al., 2000;
Herrera et al., 2001). Radioligand displacement curves were analyzed by
nonlinear regression using commercial program GRAFIT (Erithacus
Software, Surrey, UK) by fitting the total binding data to the displace-
ment models with one- or two-affinity sites (Cheng and Prusoff, 1973;
Casado´ et al., 1992). Values are parameter  SEM and differences with
respect to controls were tested for significance ( p 0.05) using Student’s
t test for unpaired samples. Goodness of fit was tested according to re-
duced  2 value given by the nonlinear regression program GRAFIT. A
modified F test was used to analyze whether the fit to the two-site model
significantly improved on the fit to one-site model, and p  0.05 was
taken as a criterion of significance; when no significant improvement
over the one-site model was detected, the p values were0.30.
Calcium determination. Transiently transfected HEK cells (106 cells/
ml) were loaded with 5 mM fura-2 AM for 30 min at 37°C. After washing
the cells, calcium peak induction was achieved by the addition of 50 nM
R-PIA and/or 200 nM CGS21680. Intracellular calcium was determined
as described previously (Ciruela et al., 2001).
Striatal synaptosomes preparation and measurement of evoked [3H]glu-
tamate release. Striatal synaptosomes prepared for immunocytochemical
analysis were obtained through a discontinuous Percoll gradient (Ro-
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drigues et al., 2005). The release of [ 3H]gluta-
mate from rat striatal nerve terminals was per-
formed as described previously (Lopes et al.,
2002; Rodrigues et al., 2005). The synapto-
someswere stimulatedwith 20mMK (isomo-
lar substitution of NaCl by KCl in the Krebs’
solution) at 3 and 9 min after starting sample
collection (S1 and S2). Tested drugs were added
2 min before S2 onward, whereas modifiers
present in S1 and S2 were added from 10 min
before starting sample collection onward. Ra-
dioactivity was expressed in terms of disinte-
grations per second per milligram of protein
(becquerels per milligram) in each chamber.
The percentage of modification of the evoked
release caused by the tested drugs was deter-
mined by measuring the percentage of modifi-
cation of the ratio S2/S1 in comparisonwith the
ratio S2/S1 of the respective control. Adenosine
(0.1–100M),N6-cyclopentyladenosine (CPA)
(100 nM), CGS (10 nM), DPCPX (50 nM),
and 5-amino-7-(2-phenylethyl)-2-(2-furyl)-
pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
(SCH58261) (50 nM), when present during S1
and S2, did not cause any effect per se on the
S2/S1 ratio. We further confirmed that the
presence of either CPA or CGS21680 during S1
and S2 did not lead to a desensitization of the
A1R-mediated or A2AR-mediated modulation
of glutamate release; in fact, when applied dur-
ing S1 and S2, CGS21680 (10 nM) enhanced
glutamate release by 28.5  1.8% during S1
and by 34.9  3.6% during S2, whereas CPA
(100 nM) inhibited glutamate release by
10.8  0.7% during S1 and by 10.4  1.0%
during S2 (n  6).
Results
A1R–A2AR heteromers in the cell surface
of transfected cells
From extracts of HEK cells transiently
transfected with Flag-A1Rs and HA-
A2ARs, the mouse anti-Flag antibody co-
immunoprecipitated a band of 	42 kDa,
which corresponds to the HA-A2AR (Fig.
1a). This band did not appear in immuno-
precipitates from cells only transfected
with the cDNA for either HA-A2ARs or
Flag-A1Rs (Fig. 1a). Conversely, in extracts from these cells, the
anti-HA antibody coimmunoprecipitated a band of 	38 kDa
corresponding to the Flag-A1R (Fig. 1a).
A1R–A2AR heteromerization was tested using BRET assays. A
positive and saturable BRET signal for the transfer of energy be-
tween A2AR-Rluc and A1R-YFP was obtained (Fig. 1b) in cells
cotransfected with a constant concentration of the A2AR-Rluc
and increasing concentrations of A1R-YFP. As the pair A2AR-
Rluc and GABA receptor GABAB2-YFP led to an undetectable
BRET signal (Fig. 1b), the hyperbolic BRET signal found for the
A2AR-Rluc plus A1R-YFP argues for the selectivity of the interac-
tion between A1Rs and A2ARs, and also suggest that the distance
between donor (A2AR-Rluc) and acceptor (A1R-YFP) is10 nm.
To assess whether these A1R–A2AR heteromers occur at the
plasma membrane level, TR-FRET was assayed in cells cotrans-
fected with Flag-A1Rs and HA-A2ARs. Because Flag and HA tags
were localized extracellularly at theN terminus of these receptors,
only the A1Rs and A2ARs localized at the plasma membrane of
intact cells were detected and gave a positive strong TR-FRET
signal (acceptor/donor emission, mean  SEM, 0.081  0.002;
n  3) compared with a mixture of cells previously transfected
with only A1Rs or A2ARs and then mixed before the assays (ac-
ceptor/donor emission, 0.011 0.002; n 3). Confocal micros-
copy analysis of nonpermeabilized HEK cells transfected with the
cDNAs for Flag-A1Rs andHA-A2ARs confirmed an overlapped dis-
tribution of the two proteins on the cell surface (Fig. 1c).
Biochemical characteristics of the A1R–A2AR heteromers
Radioligand-binding experiments using the A1R agonist [
3H]R-
PIA and the A2AR agonist [
3H]CGS21680 were performed in
A1R–A2AR cotransfected cells and cells transfected with either
A1Rs or A2ARs (Table 1). KD values for the binding of R-PIA
to A1R and for the binding of CGS21680 to A2AR were similar in
single- or double-transfected cells (Table 1), indicating that het-
eromerization does not modify the affinity of the A1Rs or A2ARs
for agonists. A1R showed the same KD for caffeine in A1R as in
A1R–A2AR transfected cells (Table 1). In single-transfected cells,
Figure 1. A1R–A2AR heteromerization in HEK cells. a, Coimmunoprecipitation of A1Rs and A2ARs. HEK-293 cells transiently
expressing HA-A2ARs alone (lane 1), HA-A2ARs plus Flag-A1Rs (lane 2), or Flag-A1Rs (lane 3) were washed, solubilized, and
processed for immunoprecipitation using anti-Flag monoclonal antibody (2g/ml; IP:Flag) or anti-HA monoclonal antibody (2
g/ml; IP:HA). Solubilized membranes (Crude) and immunoprecipitates (IP) were analyzed by SDS-PAGE and immunoblotted
using rabbit anti-A2AR polyclonal antibody (1:2000) or rabbit anti-A1R polyclonal antibody (1:1000) and HRP-conjugated goat
anti-rabbit IgG as a secondary antibody. These blots are representative of four different experiments with similar qualitative
results. IB, Immunoblot. b, BRET saturation curve. BRET wasmeasured in HEK-293 cells coexpressing A2AR-Rluc and A1R-YFP (f)
or A2AR-Rluc and GABABR2-YFP (Œ) constructs. Cotransfections were performedwith increasing amounts of plasmid DNA for the
A1R-YFP construct,whereas theDNA for theA2AR-Rluc constructwasmaintained constant. Both fluorescence and luminescence of
each sample were measured before every experiment to confirm equal expression of A2AR-Rluc while monitoring the increase of
YFP expression. The saturation curve include results obtained from five independent experiments; mBU is the BRET ratio 1000
(see Materials and Methods); error bars indicate SD of mean specific BRET ratio (mBU) values of five individual experiments
grouped as a function of the amount of fluorescence of the acceptor. AU, Arbitrary unit. c, Cell surface colocalization of A1Rs and
A2ARs in HEK cells. HEK cells were transfected with A2AR-HA, A1R-Flag, or both receptors simultaneously (coexpression). Nonper-
meabilized cotransfected cells were immunostained with mouse anti-HA monoclonal antibody and rabbit anti-Flag polyclonal
antibody. The bound primary antibodies were detected using either Alexa Fluor 488-conjugated goat anti-mouse IgG antibody or
Texas Red-conjugated goat anti-rabbit. Cells were analyzed by double immunofluorescence with confocal microscopy. Superim-
position of images reveals A1R–A2AR cell surface colocalization in yellow (merge). Scale bar, 10m.
Table 1. Equilibrium dissociation constants of A1Rs and A2ARs expressed in HEK cells
Transfection Radioligand Displacer KD
A1R 

3HR-PIA R-PIA 1.9 0.4 nM
Caffeine 90 20M
A2AR 

3HCGS21680 CGS21680 110 30 nM
Caffeine 7 1M
A1R A2AR 

3HR-PIA R-PIA 1.9 0.3 nM
Caffeine 93 33M

3HCGS21680 CGS21680 120 40 nM
Caffeine 90 20M*
A2AR D2R 

3HCGS21680 CGS21680 110 40 nM
Caffeine 5 2M
HEK cells were transfected with the indicated receptor. Membranes of these cells were incubated with 
3HR-PIA (0.8 nM) or 
3HCGS21680 (18 nM) in the
absence or presence of increasing concentrations of displacer in 50 mM Tris-HCl containing 10 mM MgCl2 and 2 U/ml adenosine deaminase. Data represent
means SEM. * p 0.001 with respect to both the KD value for A2AR in single-transfected cells and the KD value for A2AR plus D2R-cotransfected cells.
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A2ARs displayed higher affinity for caffeine than A1Rs (Table 1).
Interestingly, the affinity of A2ARs for caffeine in A1R–A2AR-
cotransfected cells was 12-fold lower to that compared with
A2AR-transfected cells ( p 0.001) (Table 1). The affinity of the
A2AR for CGS21680 and caffeine was not altered when cotrans-
fected with the dopamine D2 receptor (D2R), although they form
A2AR–D2R heterodimers (Canals et al., 2003) (Table 1).
In cells cotransfected with both A1Rs and A2ARs, but not in
cells expressing only A1Rs, the affinity of A1Rs for [
3H]R-PIA
decreased in the presence of the A2AR agonist CGS21680, indi-
cating that A2AR activation reduces the affinity of A1R for its
agonist. As illustrated in Figure 2a, the displacement of [3H]R-
PIA by CGS21680 in membranes from A1R–A2AR-cotransfected
cells was significantly ( p 0.01) better fitted by a two-site model
than by a single-sitemodel (Fig. 2a, solid vs dashed line), whereas
it was better fitted ( p 0.01) to a single-site model rather than a
two-site model in membranes from A1R single-transfected cells
(Fig. 2b, solid vs dashed line). At low concentrations of
CGS21680, when it binds preferentially to A2ARs (at concentra-
tions of CGS21680500 nM, the direct binding of CGS21680 to
A1Rs is 1%, according to the calculated affinity of A1R for
CGS21680), CGS21680 significantly ( p  0.05) decreased the
binding of [3H]R-PIA to the A1R from an EC50 value of 3.0 0.4
M to 30 10 nM (means SEM). The EC50 value corresponds
to one-half of themaximum inhibitory effect of CGS21680 on the
binding of [3H]R-PIA to the A1R (or the high-affinity site calcu-
lated using the two-site model). In contrast, the displacement of
[3H]CGS21680 by R-PIA was not affected in the membranes from
cells cotransfected with A1Rs and A2ARs (data not shown). This
means that the binding characteristics of A2ARs are preserved in the
A1R–A2ARheterodimer, whereas the binding characteristics of A1Rs
become controlled by A2ARs in this heterodimer.
The ability of A2ARs to decrease A1R-mediated effects after
formation of theA1R–A2ARheterodimerwas confirmed in exper-
iments measuring intracellular calcium levels in HEK cells tran-
siently expressing Flag-A1Rs plus HA-A2ARs. The intracellular
calcium peak induced by the A1R agonist, R-PIA (50 nM), was
similar in HEK cells transfected with A1R alone or A1R plus A2AR
(Fig. 2c) (95 15 and 86 12 nM, respectively). However, pre-
incubation with 50 nM CGS21680, which was by itself ineffective,
significantly reduced the calcium peak obtained in response to
A1R activation in cells doubly transfected with both receptors
(Fig. 2c) to 41  16 nM. This contrasted with the inability of
CGS21680 (50 nM) to affect A1R-mediated recruitment of intra-
cellular calcium in cells expressing only Flag-A1Rs. R-PIA (50 nM)
or CGS21680 (50 nM) failed tomodify intracellular calcium levels
in nontransfected HEK-293 cells (Fig. 2c).
A1R–A2AR heteromers in rat striatum
Immunoelectron microscopy, using preembedding immuno-
gold techniques, revealed the presence of A2AR immunoreactivity
along the extrasynaptic plasma membrane of axon terminals es-
tablishing asymmetric synapses (Fig. 3a), as well as in the presyn-
aptic active zone of asymmetric synapses facing dendritic shafts
and spines (Fig. 3b). A2ARs were also observed in postsynaptic
structures along the extrasynaptic and perisynaptic plasmamem-
brane of dendritic shafts and spines, establishing asymmetrical
synapses with axon terminals (Fig. 3a–c). Similarly, immunore-
activity for the A1R was localized along the extrasynaptic plasma
membrane and presynaptic active zone of axon terminals in
asymmetric synapses and along the extrasynaptic plasma mem-
brane of dendritic shafts and spines (Fig. 3d,e) establishing asym-
metrical synapses with axon terminals. Interestingly, both recep-
tors colocalized in both presynaptic and postsynaptic structures
of asymmetrical, putative glutamatergic, synapses (Fig. 3f–h).
This is the first direct anatomic evidence for adenosine A2ARs and
A1Rs colocalization in the same neuronal compartments.
To test the presence of A1R–A2AR heteromers in the rat stria-
tum, competitive-inhibition experiments by CGS21680 of
[3H]R-PIA binding were also performed in membrane prepara-
tions from rat striatum. As observed in cells cotransfected with
A1Rs and A2ARs, the obtained displacement data in rat striatal
membranes were significantly ( p 0.001) better fitted by a two-
site model than by a single-site model (Fig. 4a). The IC50 value,
which reflects the binding of CGS21680 directly to the A1R (low-
affinity site calculated using the two-site model), and the EC50
value, which refers to the effect of CGS21680 on the binding of
R-PIA to A1R (high-affinity site calculated using the two-site
model) were 1.8 0.5M and 22 6 nM, respectively (means
SEM). These values were strikingly similar to those obtained us-
ing A1R–A2AR-cotransfected cells (3.0 0.4M and 30 10 nM,
respectively). The activation of A1R with R-PIA did not modify
the affinity of A2AR for its agonist CGS21680 in rat striatal mem-
branes (data not shown), as observed in cells cotransfected with
A1Rs and A2ARs. Another correlate of the existence of A1R–A2AR
heteromers in the striatum, based on the findings obtained in
cells cotransfected with A1Rs and A2ARs, was that the affinity of
rat striatal A2ARs for caffeine was four times lower than the affin-
ity of A1Rs for caffeine (see below).
A1R–A2AR heteromeric complexes in striatal glutamatergic
nerve terminals
The preferential colocalization of A1R and A2AR in glutamatergic
terminals was confirmed by immunocytochemistry and coim-
munoprecipitation. A1R and A2AR immunoreactivity could be
Figure2. A2AR-mediatedmodulationofA1R function inHEK cells.a,b,Modulationof [
3H]R-
PIA binding to A1R by A2AR activation. HEK cells were transiently cotransfected with A1R and
A2AR (a) orwith A1R alone (b). Membranes (0.19mg/ml) of these cells were incubatedwith 0.8
nM A1R agonist [
3H]R-PIA in the absence or presence of increasing concentrations of the A2AR
agonist CGS21680 in 50mM Tris-HCl containing 10mMMgCl2 and 2U/ml adenosine deaminase.
Binding experiments were performed as described in Materials and Methods. The data were
adjusted to one single binding site (dashed line) or to two binding sites (solid line). c, Modula-
tion by A2ARs of A1R-induced Ca
2 mobilization. Transiently transfected HEK-293 cells were
loadedwith fura-2 AM, and the intracellular Ca 2mobilizationwas determined after stimula-
tion with R-PIA (50 nM) or CGS21680 (50 nM). The presence of CGS21680 decreases R-PIA-
induced Ca 2mobilization in the doubly transfected cells. These recordings are representative
of 10 different experiments with similar qualitative results.
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detected in single glutamatergic nerve ter-
minals, identified by immunostaining us-
ing antibodies against vesicular glutamate
transporters type 1 and 2 (vGluT1 and
vGluT2), which are expressed in glutama-
tergic neurons (Fremeau et al., 2001; Her-
zog et al., 2001) (Fig. 5a). Quantification
of images (n  4) showed that there is a
61  2% (in means  SEM) of glutama-
tergic terminals that are immunoreactive
for both A1Rs and A2ARs, whereas only
1.5  0.9% are endowed with A2ARs but
not with A1Rs and 9 1% with A1Rs but
not with A2ARs (Fig. 5b). The number of
glutamatergic terminals that do not ex-
press any of the receptors is 30%. As
shown in Figure 5c, an antibody against
A2ARs was able to immunoprecipitate
A1Rs from solubilized rat striatal nerve
terminals. These results demonstrate that
A1Rs and A2ARs can form heteromeric re-
ceptor complexes in the striatal nerve
terminals.
To prove a direct effect of presynaptic
A1R and A2AR on glutamate release, the
evoked release of glutamate was analyzed
from superfused rat striatal nerve termi-
nals loaded with [3H]glutamate. The A1R
agonist CPA (100 nM) inhibited (mean
SEM; 31.6 2.6%, n 3) the K-evoked
[3H]glutamate release and this effect was
prevented by preincubation with the se-
lective A1R antagonist DPCPX (50 nM)
(Fig. 6a), which did not have any signifi-
cant effect on its own (data not shown).
The inhibitory effect of CPA was also pre-
vented when synaptosomes were preincu-
bated with the A2AR agonist CGS21680
(10 nM) (Fig. 6a), showing the A2AR-
mediated negative modulation of A1R
function, as occurred inHEK cells. In con-
trast, CGS21680 facilitated (57.7  6.4%;
n 3) the K-evoked [3H]glutamate release, and this effect was
prevented by the selective A2A receptor antagonist SCH58261 (50
nM) but was not modified when synaptosomes were preincu-
batedwithCPA (Fig. 6a). SCH58261 alone did not have any effect
on glutamate release (data not shown).WhenCGS21680 (10 nM)
and CPA (100 nM) were simultaneously added, a facilitatory ef-
fect was obtained (44.5  8.6%; n  6), which was significantly
( p 0.05) higher than the arithmetic sum of the separate effects
of 10 nM CGS21680 and 100 nM CPA (i.e., if these effects were
purely additive), as illustrated by the dashed bar in Figure 6a.
Overall, these results agree with the occurrence of functional
A1R–A2AR heteromers in striatal glutamatergic nerve terminals
testified by the ability of A2ARs to abrogate A1R-mediated effects.
Finally, the addition of increasing concentrations of adeno-
sine (0.1–100 M) demonstrated its ability to biphasically mod-
ulate the evoked release of glutamate from striatal nerve termi-
nals. At a concentration of 0.1M, adenosine did not significantly
modify glutamate release (n 6); at 1M, adenosine significantly
decreased (23.6 4.7%; n 8; p 0.05), whereas, at 10 and 100
M, it significantly facilitated K-evoked [3H]glutamate (30.4
7.5 and 17.6 3.5%; n 6; p 0.05 in both cases).
A1R–A2AR intramembrane interaction and caffeine tolerance
An unresolved issue about caffeine is the strong tolerance for
many of its behavioral and biochemical effects that develop after
chronic treatment (Holtzman and Finn, 1988; Jacobson et al.,
Figure 3. A1R–A2AR colocalization in rat striatum. a– c, Immunogold particles for the A2ARs were observed at the presynaptic
level along the extrasynaptic plasma membrane (arrows) of axon terminal (B), as well as in the presynaptic active zone (crossed
arrows), facing dendritic shafts (D) and spines. A2ARs were also observed at the postsynaptic level along the extrasynaptic and
perisynaptic plasma membrane of dendritic shafts (D) and spines (arrowheads), establishing asymmetrical synapses with axon
terminals. d, e, Similarly to A2ARs, immunogold particles for the A1R were localized along the presynaptic active zone of axon
terminals (B; crossed arrows) and along the extrasynaptic plasma membrane of dendritic shafts (D) and spines (arrowheads)
establishing asymmetrical synapses with axon terminals. f, g, Presynaptic colocalization of A1Rs and A2ARs. Peroxidase reaction
product (immunoreactivity for A1Rs) filled axon terminals (B) establishing asymmetrical synapses with dendritic shafts (D) or
spines (S), in which immunoparticles (immunoreactivity for A2ARs) were localized along the extrasynaptic plasma membrane
(arrows).h, Postsynaptic colocalizationofA1Rs andA2ARs. Peroxidase reactionproduct (immunoreactivity forA1Rs) filleddendritic
shafts (D) establishing asymmetrical synapses with axon terminals (B), in which immunoparticles (immunoreactivity for A2ARs)
were localized along the synaptic plasma membrane (arrowhead). Scale bar, 0.2m.
Figure 4. Intramembrane A1R–A2AR interaction in rat striatum. Effect of chronic caffeine
treatment. Modulation of [ 3H]R-PIA binding to A1Rs by A2AR activation. Striatal membranes
(0.25mg/ml) of control (a) or caffeine-treated rats (b)were incubatedwith 0.9 nM [ 3H]R-PIA in
the absence or presence of increasing concentrations of CGS21680 in 50mM Tris-HCl containing
10 mM MgCl2 and 2 U/ml adenosine deaminase. Binding experiments were performed as de-
scribed in Materials and Methods. The data were adjusted to one single binding site (dashed
line) or to two binding sites (solid line).
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1996; Fredholm et al., 1999). To test a possible role of A1R–A2AR
heteromers in this phenomenon, competitive–inhibition experi-
ments of [3H]R-PIA binding using CGS21680were performed in
striatal membrane preparations of caffeine-treated rats (1 mg/ml
in the drinking water for 14 d; average caffeine consumption,
mean  SEM, 120  4 mg  kg1  d1), and the results com-
pared with those obtained in naive animals. Again, the displace-
ment curve of [3H]R-PIA binding by CGS21680 in striatal mem-
branes from caffeine-treated rats was significantly ( p  0.001)
better fitted by a two-site model than by a single-site model (Fig.
4b). The IC50 value (mean SEM) corresponding to the binding
of CGS21680 to A1R (1.7 0.5 mM) was similar to that obtained
in naive rats (1.8 0.5 M) as well as the [3H]R-PIA binding to
these striatal membranes when no displacer was present (Fig. 4).
However, the inhibition of the [3H]R-PIA binding to A1R when
CGS21680 binds to the A2AR displayed an EC50 value about
threefold lower than the value obtained in naive rats (mean 
SEM, 8  3 and 22  6 nM, respectively). These results indicate
that caffeine pretreatment alters the function of the A1R–A2AR
heteromers, increasing significantly ( p 0.02) the potency of an
A2A agonist to modulate A1Rs. The agonist binding characteris-
tics for both striatal A1R and A2AR were not modified by caffeine
treatment. Thus, in competition experiments using [3H]R-PIA,
KD values (means  SEM) for the binding of R-PIA to A1R in
control and caffeine-treated animals were 0.1 0.05 and 0.13
0.06 nM, respectively. In competition experiments using
Figure 5. Adenosine receptors in glutamatergic striatal nerve terminals. a, Immunocyto-
chemical identification of A2AR (green) and A1R (blue) in the glutamatergic population of rat
striatal nerve terminals (identified as vGluT-1 and vGluT-2 immunoreactive; red). In the super-
imposed picture of this triple-immunocytochemical labeling (merge) of this representative
field, the arrows indicate theA1R/A2AR/vGluT-containing nerve terminals.b, The quantification
of images of three different fields per coverslip from four experiments using different synapto-
somal preparations from different animals confirmed the predominant colocalization of A1Rs
and A2ARs in rat striatal glutamatergic terminals (results aremeans SEM). c, Coimmunopre-
cipitation of A1R and A2AR from rat striatal synaptosomes. Solubilized synaptosomes were
immunoprecipitatedusing rabbit anti-A1Rpolyclonal antibody (5g) (lane1), irrelevant rabbit
polyclonal antibody (5g) (lane2), andmouse anti-A2ARmonoclonal antibody (2g) (lane3).
Solubilized membranes (Crude) and immunoprecipitates (lanes 1–3) were analyzed by SDS-
PAGE and immunoblotted using rabbit rabbit anti-A1R antibody (1:1000) and HRP-conjugated
swine anti-rabbit IgG as a secondary antibody. IB, Immunoblot.
Figure 6. Effect of A1R and A2AR activation on evoked release of glutamate from striatal
nerve terminals. Superfused synaptosomes, previously loaded with [ 3H]glutamate, were
chemically (20mMK for 30 s) stimulated twice (S1 and S2).a, CPA (100nM) andCGS21680 (10
nM), present in S2, inhibited and facilitated, respectively, the evoked release of glutamate in a
manner prevented by the A1R and A2AR antagonists DPCPX (50 nM) and SCH58261 (50 nM),
respectively (present in S1 and S2). The inhibitory effect of CPA (100 nM) was also abolished
when CGS21680 (10 nM) was present during S1 and S2, whereas the facilitatory effect of
CGS21680was notmodifiedwhen CPA (100 nM)was present in S1 and S2. Coapplication of CPA
(100 nM) and CGS (10 nM) in S2 facilitated the evoked release of glutamate. The dashed bar
illustrates the arithmetic sum of the effects of 10 nM CGS21680 and 100 nM CPA, if these effects
were purely additive. The results are means SEM of three to seven experiments. *p 0.05
versus 0%; **p 0.05 between bars.b, Increasing concentrations of adenosine (0.1–100M)
produced a biphasic effect, with with low and high concentrations inhibiting and stimulating
the evoked release of glutamate, respectively. The results are means SEM of six to eight
experiments. *p 0.05 versus 0%.
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[3H]CGS21680, KD values for the binding of CGS21680 to A2AR
in control and caffeine-treated animals were 111 43 and 120
60 nM, respectively. However, A2ARs displayed a lower affinity for
caffeine in membranes from caffeine-pretreated rats (KD 
290  80 M) compared with control rats (KD  80  10 M).
This effect was significant ( p  0.001) and specific for A2ARs,
because the A1Rs had the same affinity for caffeine in both naive
and caffeine-treated animals (KD 19 5 and 13 6 M).
Discussion
Either A1Rs or A2ARs are capable of forming heteromers with
other G-protein receptors, such as dopamine, glutamate, and
ATP receptors (Agnati et al., 2003). However, the existence of
heteromers constituted by different adenosine receptor subtypes
had not been reported. In the present study, a precise colocaliza-
tion of A1Rs and A2ARs at the presynaptic level of striatal gluta-
matergic synapses was demonstrated by ultrastructural analysis.
The results of immunocytochemistry and coimmunoprecipita-
tion experiments showed that the striatal A1R–A2AR heteromer is
preferentially localized in the striatal glutamatergic terminals,
and the experiments of evoked glutamate release directly demon-
strated the ability of presynaptic A2ARs to control the A1R-
mediated modulation of striatal glutamate release. Radioligand-
binding experiments demonstrated that a main biochemical
characteristic of the A1R–A2AR heteromer is the ability of A2AR
activation to reduce the affinity of the A1R for agonists. Together,
the present results indicate that the A1R–A2AR heteromer plays a
role in the adenosine-mediated fine-tuning modulation of stria-
tal glutamatergic neurotransmission.
Under basal conditions, the relatively low extracellular levels
of adenosine preferentially stimulate A1Rs, which show a higher
affinity for adenosine than A2ARs (Fredholm et al., 2001). The
preferential A1R stimulation in the A1R–A2AR heteromer inhibits
glutamatergic neurotransmission. Under conditions of stronger
adenosine release, A2A receptor activation in the A1R–A2AR hetero-
mer would block A1R-mediated function, and the overall result will
be a facilitation of the evoked release of glutamate (supplemental
figure, available at www.jneurosci.org as supplemental material).
Thus, the functional characteristics of theA1R–A2ARheteromers are
different fromA1 orA2A receptors and provide a rationale to under-
stand how adenosinemight facilitate or inhibit glutamatergic trans-
mission depending on the concentration of adenosine. In fact, in-
creasingconcentrationsofadenosinedemonstratedabiphasic effect,
with low and high concentrations of adenosine inhibiting and stim-
ulating glutamate release from striatal nerve terminals, respectively.
The present study also provides new information about the
main pharmacological targets of caffeine, A1Rs and A2ARs. To
our knowledge, this is the first study that analyses simultaneously
the affinity of A1Rs and A2ARs for caffeine in transfected cells and
brain (striatal) tissue. Previous studies using cloned transfected
receptors showed that A2AR displays higher affinity for caffeine
than A1R (Fredholm et al., 1999, 2001). In contrast, the results
obtained from brain tissue are more variable, showing either no
difference (Muller et al., 1997), a preferential affinity of A2AR
(Svenningsson et al., 1999), or a preferential affinity of A1R for
caffeine (Antoniou et al., 2005). Significant differences in the
affinity of A2AR for caffeine were observed depending on its se-
lective association with A1R. In agreement with previous studies
(Fredholm et al., 2001), A2ARs display higher affinity for caffeine
than A1Rs when studied in single-transfected cells. However,
A1R–A2AR, but not A2AR–D2R, heteromerization was associated
with a prominent decrease in the affinity of A2AR for caffeine,
with a KD value comparable with that observed in striatal tissue.
Taking also into account that the “biochemical fingerprint” of the
A1R–A2ARheteromer (the ability of A2AR activation to reduce the
affinity of the A1R for agonists) could be demonstrated in striatal
membrane preparations, the present results indicate that a signif-
icant amount of striatal A2A receptors are forming heteromers
with A1Rs. However, although most A1Rs and A2ARs localized in
the glutamatergic terminals are forming part of A1R–A2AR het-
eromers, in the striatum caffeine can also target A2ARs not inter-
acting with A1Rs localized in the dendritic spine of GABAergic
enkephalinergic neurons (Rosin et al., 2003), where they can
form heteromers with dopamine D2R or metabotropic mGlu5
receptors (Ferre´ et al., 2002; Agnati et al., 2003; Canals et al.,
2003). In fact, A2AR in the A2A-D2R heteromer has a higher affin-
ity for caffeine than the A2AR in the A1R–A2AR heteromer (Table
1). The blockade of these postsynaptic A2ARs could explain the
decrease in the striatal expression of immediate-early genes and
preproenkephalin mRNA and increased phosphorylation of
DARPP-32 (dopamine- and cAMP-regulated phosphoprotein
32) (at threonine 75) described after acute caffeine treatments
(Svenningsson et al., 1995; Lindskog et al., 2002).
The functional characteristics of the A1R–A2AR heteromers
also allow understanding the different effects operated under
acute and chronic caffeine administration. Because at relatively
low adenosine levels there is little occupancy of A2ARs, most of
the behavioral and biochemical effects after an acute administra-
tion of caffeine are most probably attributable to A1R blockade
(Snyder et al., 1981; Solinas et al., 2002, 2005; Karcz-Kubicha et
al., 2003; Quarta et al., 2004a,b; Antoniou et al., 2005). In fact, the
acute systemic or intrastriatal administration of caffeine en-
hances striatal glutamate release (Solinas et al., 2002; Quarta et
al., 2004a,b). A significant finding of the present study was the
increased antagonistic interaction between A1R and A2AR in the
A1R–A2AR heteromer with chronic caffeine treatment. But, apart
from the affinity of the A1R and A2AR for adenosine and caffeine
and the A1R–A2AR intramembrane interaction, one more vari-
able plays a substantial role when analyzing the effects taking
place after chronic caffeine administration. Chronic treatment
with the methylxanthine leads to an increase in the plasma and
extracellular levels of adenosine (Conlay et al., 1997; Andresen et
al., 1999). The same treatment with caffeine (1 mg/ml in the
drinking water for 14 d) used in the present study was reported to
produce a 10-fold increase in plasma adenosine levels (Conlay et
al., 1997). Under chronic caffeine treatment (or other conditions
leading to increased adenosine levels), adenosine also binds and
activates A2AR, which, in addition, has a reduced affinity for caf-
feine. This likely scenario would lead to a situation in which the
increased levels of adenosine acting on A2AR would potently in-
hibit A1R function by means of the increased A1R–A2AR in-
tramembrane interaction. Under these conditions, caffeine
would have little effect onA1Rs, whichwould already be inhibited
as a consequence of the increased A1R–A2AR intramembrane in-
termolecular interaction. In fact, recent studies show a predom-
inant A2AR antagonist behavioral and biochemical profile of caf-
feine under chronic administration with tolerance to its A1R
antagonistic effects (Karcz-Kubicha et al., 2003; Quarta et al.,
2004a). The present results suggest that an increased A1R–A2AR
interaction in the A1R–A2AR heteromer is involved in the toler-
ance to the psychostimulant effects of caffeine.
In conclusion,we have demonstrated that A1Rs andA2ARs can
form heteromers in striatum where they modulate glutamatergic
neurotransmission and whose existence may help in compre-
hending the mechanisms underlying the behavioral effects pro-
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duced by acute or chronic consumption of caffeine, the most
consumed psychoactive drug in the world.
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